NextGen Oncomine Myeloid 69 Gene Panel

Also known as: NextGen : Oncomine Myeloid Panel (69 Gene), EDTA Blood

50+ booked in last 3 days

No special precautions

Sample Type

Blood

Recommended for

Male, Female

Report

Within 24 Hours

Blood test at Home

NABL & CAP Accredited Labs

Accurate & Quality Test Reports

Trusted by Leading Doctors & Hospitals

Overview

The NextGen Oncomine Myeloid 69 Gene Panel is an advanced genetic testing method designed to analyze 69 specific genes associated with myeloid disorders. Using next-generation sequencing technology, this panel identifies genetic mutations and variations that contribute to conditions like myelodysplastic syndromes, myeloproliferative neoplasms, and acute myeloid leukemia. By offering insights into the genetic basis of these disorders, the panel empowers healthcare professionals to make informed diagnostic and treatment decisions, potentially leading to more personalized and effective patient care.

NextGen : Oncomine Myeloid Panel (69 Gene), EDTA Blood Price

Metropolis Healthcare is a leading diagnostics centre and pathology lab in India equipped with the latest state-of-the-art technologies that provides the NextGen : Oncomine Myeloid Panel (69 Gene), EDTA Blood with a clear pricing structure.

The NextGen : Oncomine Myeloid Panel (69 Gene), EDTA Blood Price in Mumbai is ₹ 35,000 .

We are committed to deliver accurate and quality results from the best labs in India with complete transparency regarding test cost and turnaround time. No matter where you are, we strive to offer patients high-quality service that is affordable and accessible.

Frequently Asked Questions

What does Oncomine Myeloid Gene Panel measure?

The Oncomine Myeloid Gene Panel measures genetic mutations present in various genes associated with myeloid malignancies. This test identifies specific changes in the DNA sequence.

Why is the Oncomine Myeloid Gene Panel done?

• To diagnose myeloid malignancies, such as AML and MDS • To determine the specific genetic mutations present for targeted therapy selection • To monitor treatment response and disease progression • To assess the risk of relapse or disease transformation in patients with myeloid disorders

When is Oncomine Myeloid Gene Panel recommended and who should take the test?

The Oncomine Myeloid Gene Panel is recommended when • a patient presents with symptoms suggestive of myeloid malignancies, such as unexplained anaemia or recurrent infections, • a previous diagnosis of a myeloid disorder requires further characterisation, or • treatment decisions need to be guided based on specific genetic mutations identified in the patient's cancer cells.

What if the results of the Oncomine Myeloid Gene Panel are abnormal?

Abnormal results from the Oncomine Myeloid Gene Panel may indicate the presence of specific genetic mutations associated with myeloid malignancies.

What to expect during the Oncomine Myeloid Gene Panel?

During the test, a small blood sample will be collected using a needle inserted into a vein in your arm. The sample will be sent to the laboratory for genetic analysis using a Next-Generation Sequencing (NGS) method.

What preparations are required before the Oncomine Myeloid Gene Panel?

Inform your healthcare provider about any medications, supplements, or medical history relevant to your condition. Also, tell them if you have any specific requirements.

What other tests may be ordered with the Oncomine Myeloid Gene Panel?

• Bone marrow aspiration and biopsy: This procedure helps evaluate the cellular components of bone marrow for a comprehensive diagnosis. • Flow cytometry: This test analyses the presence of specific proteins on the surface of cells and aids in diagnosing different types of blood cancers and disorders.

What is the Oncomine Myeloid Gene Panel also known as?

Myeloid Next Generation Sequencing Panel or Comprehensive Myeloid Genetic Testing

What is acute myeloid leukemia (AML)?

Acute Myeloid Leukaemia (AML) is a cancer that affects the bone marrow and blood cells. It is characterised by the rapid growth of abnormal white blood cells, which interfere with the production of normal blood cells. AML can cause symptoms such as fatigue, frequent infections, and easy bleeding or bruising.

Ratings & Reviews (0)

No reviews available

Why Metropolis?

Metropolis has a team of 200 senior pathologists and over 2000 technicians delivering diagnostic solutions in the areas of routine, semi specialty and super specialty domains like Oncology, Neurology, Gynaecology, Nephrology and many more.

We offer a comprehensive range of 4000+ clinical laboratory tests and profiles, which are used for prediction, early detection, diagnostic screening, confirmation and/or monitoring of the disease.